Periampullary adenocarcinoma

From - A Hematology Oncology Wiki
Jump to: navigation, search

Section editor Page editor
Neeta K. Venepalli, MD, MBA
Chicago, IL
Ivy Abraham.JPG
Ivy Abraham, MD
Chicago, IL
regimens on this page
variants on this page

Liver cancer or hepatobiliary cancer comprises cancers that arise within the liver and its hepatocytes (hepatocellular carcinoma) and the biliary tract cancers, which include bile duct cancer/cholangiocarcinoma and gallbladder cancer.




Adjuvant therapy


back to top


Study Evidence Comparator Efficacy
Neoptolemos et al. 2012 (ESPAC-3) Phase III (C) 5-FU & Leucovorin
Seems not superior

Preceding treatment

  • Surgery


  1. Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, Carter R, Tebbutt NC, Dervenis C, Smith D, Glimelius B, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Ghaneh P, Halloran CM, Lerch MM, Oláh A, Rawcliffe CL, Verbeke CS, Campbell F, Büchler MW; European Study Group for Pancreatic Cancer. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA. 2012 Jul 11;308(2):147-56. Erratum in: JAMA. 2012 Nov 14;308(18):1861. link to original article PubMed